|
3ÁÙ¸ð¾ç
|
|
 |
OWpfxIkYDWlaIa |
 |
413 |
|
 |
I saw your advert in the paper http://xvedio.in.net/xvidoes/ www.xvidoes
Immunocore's technology relies on a new type of medicines it calls "ImmTACs." These drugs exploit the power of T cell receptors -- a part of the immune system -- to recognize changes that occur inside cells during cancer or viral infection. ImmTACs then activate the immune system to kill targeted cells. |
 |
 |
Darryl |
 |
2019-05-22 04:25:15 |
|
|
|
|
|
|
|
|